These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25663096)

  • 1. Intention to treat analysis versus per protocol analysis of trial data.
    Sedgwick P
    BMJ; 2015 Feb; 350():h681. PubMed ID: 25663096
    [No Abstract]   [Full Text] [Related]  

  • 2. Intention to treat and per protocol analysis in clinical trials.
    Tripepi G; Chesnaye NC; Dekker FW; Zoccali C; Jager KJ
    Nephrology (Carlton); 2020 Jul; 25(7):513-517. PubMed ID: 32147926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intention-to-treat analysis in RCTs.
    El-Masri MM
    Can Nurse; 2015 Apr; 111(3):9. PubMed ID: 25975038
    [No Abstract]   [Full Text] [Related]  

  • 4. Intention-to-treat in randomized controlled trials: recommendations for a total trial strategy.
    Polit DF; Gillespie BM
    Res Nurs Health; 2010 Aug; 33(4):355-68. PubMed ID: 20645423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary imputation methods impact efficacy results in hidradenitis suppurativa clinical trials.
    Frew JW
    J Am Acad Dermatol; 2020 Aug; 83(2):663-665. PubMed ID: 32247874
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the results of intent-to-treat, per-protocol, and g-estimation in the presence of non-random treatment changes in a time-to-event non-inferiority trial.
    Matsuyama Y
    Stat Med; 2010 Sep; 29(20):2107-16. PubMed ID: 20552682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of protocol design changes on clinical trial performance.
    Getz KA; Wenger J; Campo RA; Seguine ES; Kaitin KI
    Am J Ther; 2008; 15(5):450-7. PubMed ID: 18806521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing phase III studies in hospice/palliative care. a solution that sits between intention-to-treat and per protocol analyses: the palliative-modified ITT analysis.
    Currow DC; Plummer JL; Kutner JS; Samsa GP; Abernethy AP
    J Pain Symptom Manage; 2012 Oct; 44(4):595-603. PubMed ID: 22819439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intention to treat analysis and per protocol analysis: complementary information.
    Prescrire Int; 2012 Dec; 21(133):304-6. PubMed ID: 23373104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Per-Protocol Analyses of Pragmatic Trials.
    Hernán MA; Robins JM
    N Engl J Med; 2017 Oct; 377(14):1391-1398. PubMed ID: 28976864
    [No Abstract]   [Full Text] [Related]  

  • 11. Analyzing symptom management trials: the value of both intention-to-treat and per-protocol approaches.
    Given B; Given CW; Sikorskii A; You M; McCorkle R; Champion V
    Oncol Nurs Forum; 2009 Nov; 36(6):E293-302. PubMed ID: 19887342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rethinking the intention-to-treat principle: one size does not fit all.
    Oude Rengerink K; Mitroiu M; Teerenstra S; Pétavy F; Roes KCB
    J Clin Epidemiol; 2020 Sep; 125():198-200. PubMed ID: 32380178
    [No Abstract]   [Full Text] [Related]  

  • 13. Dropout rates for intent-to-treat and per protocol analyses.
    Stewart WC; Jackson AL; Jenkins JN
    Am J Ophthalmol; 2004 Apr; 137(4):639-45. PubMed ID: 15059702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistics Commentary Series: Commentary #10-Dealing With Drop-Outs.
    Streiner DL
    J Clin Psychopharmacol; 2015 Oct; 35(5):496-8. PubMed ID: 25803367
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategy for intention to treat analysis in randomised trials with missing outcome data.
    White IR; Horton NJ; Carpenter J; Pocock SJ
    BMJ; 2011 Feb; 342():d40. PubMed ID: 21300711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond intention to treat: what is the right question?
    Shrier I; Steele RJ; Verhagen E; Herbert R; Riddell CA; Kaufman JS
    Clin Trials; 2014 Feb; 11(1):28-37. PubMed ID: 24096636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping clinical trials by design.
    Whitehead J
    Nat Rev Drug Discov; 2004 Nov; 3(11):973-7. PubMed ID: 15520819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Katrina on clinical research: lessons learned.
    Slakey DP
    J La State Med Soc; 2007; 159(3):166-8. PubMed ID: 17694937
    [No Abstract]   [Full Text] [Related]  

  • 20. How to write a surgical clinical research protocol: literature review and practical guide.
    Rosenthal R; Schäfer J; Briel M; Bucher HC; Oertli D; Dell-Kuster S
    Am J Surg; 2014 Feb; 207(2):299-312. PubMed ID: 24262932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.